Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Azucena Castrillo"'
Publikováno v:
Platelets, Vol 33, Iss 1, Pp 27-34 (2022)
Platelet transfusion, both prophylactic and therapeutic, is a key element in modern medicine. Currently, the standard platelet product for clinical use is platelet concentrates at room temperature (20–24°C) under gentle agitation. As this temperat
Externí odkaz:
https://doaj.org/article/a69371654235454ba3774e7e9b1710f0
Autor:
Carina Arcas Otero, Arturo Pereira Saavedra, Azucena Castrillo Fernández, Mª Dolores Vilariño López
Publikováno v:
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 61(3)
Platelet concentrates(PCs) prepared with pathogen reduction technologies(PRT) are being used in routine treatment of onco-haematological patients since several years but less data are available for other pathologies.The aim of the study was to compar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3d9d50cb078147ec99fdcc9ed8e1ded
https://pubmed.ncbi.nlm.nih.gov/35074272
https://pubmed.ncbi.nlm.nih.gov/35074272
Publikováno v:
Platelets. 33(1)
Platelet transfusion, both prophylactic and therapeutic, is a key element in modern medicine. Currently, the standard platelet product for clinical use is platelet concentrates at room temperature (20-24°C) under gentle agitation. As this temperatur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8c4f5bbcad7cf760b538a281a0b52bc
https://pubmed.ncbi.nlm.nih.gov/34423718
https://pubmed.ncbi.nlm.nih.gov/34423718
Autor:
Almudena Díaz Pereira, Carina Arcas Otero, Azucena Castrillo Fernández, Maria Adelantado Pérez, Marion C. Lanteri
Publikováno v:
RUNA. Repositorio da Consellería de Sanidade e Sergas
Servizo Galego de Saúde (SERGAS)
Servizo Galego de Saúde (SERGAS)
BACKGROUND: Platelet concentrates (PCs) treated by the pathogen inactivation technology (PI) using amotosalen and UVA illumination (PI-PCs) can be manufactured in additive solutions (PAS-III and PAS-IIIM) or in 100% Plasma. Quality control (QC) is an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bdb6c36a806efb731b8513f8a8d05b2
https://doi.org/10.1016/j.transci.2018.12.004
https://doi.org/10.1016/j.transci.2018.12.004
Publikováno v:
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 59(6)
Introduction Temperature and time conditions during storage and distribution of blood components (BC) and their permissible deviations are strictly regulated. The degree of compliance with these requirements in daily practice of transfusion services
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5e6eb92029984e0d23fd0565dedaefe
https://pubmed.ncbi.nlm.nih.gov/32921561
https://pubmed.ncbi.nlm.nih.gov/32921561
Autor:
Serena Lacerenza, María N. Barrachina, Lidia Hermida-Nogueira, Irene Izquierdo, Azucena Castrillo, María García-Vence, Susana B. Bravo, Ángel García
Publikováno v:
Journal of proteomics. 210
In blood banks, platelets are stored until 7 days after a pathogen reduction technology (PRT) treatment, Mirasol® (vitamin B2 plus UVB light) in the present case. The storage time under these conditions may have an impact on platelets and their rele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc2ad130e5657cefa7dc14ddeaf527ed
https://pubmed.ncbi.nlm.nih.gov/31605789
https://pubmed.ncbi.nlm.nih.gov/31605789
Autor:
Mercedes Villamayor, Alfredo Campos, Azucena Castrillo, M. Dolores Vilariño, Rachel Kilian, Marcia Cardoso
Publikováno v:
Transfusion Medicine and Hemotherapy
Introduction: This study assessed the feasibility, performance, and safety of Mirasol®-treated platelet concentrates (M-PC) stored for up to 7 days. Methods: This prospective observational study was approved by the ethical committee of the Universit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c878165437ed99850d5a4ecd72ae8f2a
Publikováno v:
Transfusion Medicine and Hemotherapy. 40:44-48
Background: The Mirasol pathogen reduction technology (PRT) system uses riboflavin and ultraviolet light and is currently approved and used in Europe for the treatment of platelets and plasma. Mirasol treatment is intended to reduce the infectious pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4116a7386a4271b89b8ed6e6103b82e
https://doi.org/10.1159/000345679
https://doi.org/10.1159/000345679
Autor:
Jorge Monge, Azucena Castrillo, Ángel Pajares, Rosa M. Maymo, José Luis Arroyo, Marta Yáñez, Carmen Muñoz, Luis Larrea, Teresa Jimenez-Marco, María L. Jurado
Publikováno v:
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 56(3)
Background Diverse variables are involved in apheresis platelet collection, processing and storage. This survey shows how these are realized in Spain. Method An analysis of collected data was performed in a questionnaire completed by ten Transfusion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7701a184299b4f8a544ad38f2e724a01
https://pubmed.ncbi.nlm.nih.gov/28319015
https://pubmed.ncbi.nlm.nih.gov/28319015
Autor:
Miguel Ángel Vesga, Iñigo Romon, José Manuel Cárdenas, Manuel Algora, Azucena Castrillo, Joan Ramon Grifols, Pilar Ortiz, Miguel Lozano, Alfred Mingo
Publikováno v:
Medicina Clínica. 125:389-396
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18f46c19eb77149cd0762ff06276f96f
https://doi.org/10.1157/13079172
https://doi.org/10.1157/13079172